Skip to main content

Advertisement

Log in

Fibrinogen is not a prognostic factor for response to HELP-apheresis in sudden sensorineural hearing loss (SSHL)

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Higher levels of fibrinogen or cholesterol were associated with improved hearing recovery in SSHL patients after treatment with HELP-apheresis (Heparin-induced extracorporeal LDL precipitation apheresis). The present trial was performed to demonstrate HELP-related effects on relevant metabolic and inflammatory parameters in the context of SSHL treatment. In the framework of a single arm non-controlled trial, we investigated the variation of metabolic and inflammatory parameters using HELP-apheresis for a defined group of 100 patients with SSHL. Based on cut off inclusion criteria (Serum LDL-cholesterol >1.6 g/l and/or fibrinogen >2.0 g/l, SSHL in minimum three frequencies more than 30 dB, time after event not longer than 6 days), the protocol followed a strict time line with one single shot HELP-apheresis and follow-up monitoring including laboratory parameters at six defined time points. If HELP-apheresis could not effect improvement of hearing on day 5, additional corticosteroid treatment was applied. Concentration of anti-inflammatory IL-10 increased while other proinflammatory parameters declined. Serum levels of all measured sterols and apolipoproteins decreased significantly. None of the investigated parameters were suitable to predict hearing improvement of the patients. Levels of fibrinogen and LDL-cholesterol were not prognostic for outcome after HELP-apheresis. A significant (p < 0.001) increase of anti-inflammatory IL-10 after apheresis was notable, while most of the proinflammatory parameters declined. Despite the limited validity of a single arm non-controlled trial, these alterations on immune modulating factors indicate possible secondary pleiotropic effects caused by HELP-apheresis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, Brown SR, Fife TD, Ford P, Ganiats TG, Hollingsworth DB, Lewandowski CA, Montano JJ, Saunders JE, Tucci DL, Valente M, Warren BE, Yaremchuk KL, Robertson PJ (2012) Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 146(3 Suppl):S1–S35

    Article  PubMed  Google Scholar 

  2. Rauch SD (2008) Clinical practice: idiopathic sudden sensorineural hearing loss. N Engl J Med 359(8):833–840

    Article  CAS  PubMed  Google Scholar 

  3. Conlin AE, Parnes LS (2007) Treatment of sudden sensorineural hear- ing loss, I: a systematic review. Arch Otolaryngol Neck Surg 133:573–581

    Article  Google Scholar 

  4. Ballesteros F, Alobid I, Tassies D, Reverter JC, Scharf RE, Guilemany JM, Bernal-Sprekelsen M (2009) Is there an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors? Audiol Neurootol 14(3):139–145

    Article  CAS  PubMed  Google Scholar 

  5. Lin RJ, Krall R, Westerberg BD, Chadha NK, Chau JK (2012) Systematic review and meta-analysis of the risk factors for sudden sensorineural hearing loss in adults. Laryngoscope 122(3):624–635

    Article  PubMed  Google Scholar 

  6. Suckfüll M, Wimmer C, Reichel O, Mees K, Schorn K (2002) Hyperfibrinogenemia as a risk factor for sudden hearing loss. Otol Neurotol Off lication Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 23(3):309–311

    Article  Google Scholar 

  7. Lane DW, l’Anson S (1994) Viscosimetric effect of fibrinogen. J Clin Pathol 47(11):1004–1005

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Mösges R, Köberlein J, Heibges A, Erdtracht B, Klingel R, Lehmacher W (2009) Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. Eur Arch Otorhinolaryngol 266(7):943–953

    Article  PubMed  Google Scholar 

  9. Suckfüll M (2002) Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 360(9348):1811–1817

    Article  PubMed  Google Scholar 

  10. Bianchin G, Russi G, Romano N, Fioravanti P (2011) Role of H. E. L. P. -apheresis in the treatment of sudden sensorineural hearing loss in a group of 230 patients. Acta Otorhinolaryngol Ital, pp 395–398

  11. Ullrich H, Kleinjung T, Steffens T, Jacob P, Schmitz G, Strutz J (2004) Improved treatment of sudden hearing loss by specific fibrinogen aphaeresis. J Clin Apher 19(2):71–78

    Article  PubMed  Google Scholar 

  12. Kirschkamp T, Schmid-Schönbein H, Weinberger A, Smeets R (2008) Effects of fibrinogen and alpha2-macroglobulin and their apheretic elimination on general blood rheology and rheological characteristics of red blood cell aggregates. Ther Apher Dial Off Peer reviewed J Int Soc Apher Japanese Soc Apher Japanese Soc Dial Ther 12(5):360–367

    CAS  Google Scholar 

  13. Teupser D, Baber R, Ceglarek U, Scholz M, Illig T, Gieger C, Holdt LM, Leichtle A, Greiser KH, Huster D, Linsel-Nitschke P, Schäfer A, Braund PS, Tiret L, Stark K, Raaz-Schrauder D, Fiedler GM, Wilfert W, Beutner F, Gielen S, Grosshennig A, König IR, Lichtner P, Heid IM, Kluttig A, El Mokhtari NE, Rubin D, Ekici AB, Reis A, Garlichs CD, Hall AS, Matthes G, Wittekind C, Hengstenberg C, Cambien F, Schreiber S, Werdan K, Meitinger T, Loeffler M, Samani NJ, Erdmann J, Wichmann H-E, Schunkert H, Thiery J (2010) Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet 3(4):331–339

    Article  CAS  PubMed  Google Scholar 

  14. Ramunni A, Quaranta N, Saliani MT, Fallacara RA, Ria R, Ranieri G (2006) Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss? Ther Apher Dial 10(3):282–286

    Article  PubMed  Google Scholar 

  15. Fujioka M, Kanzaki S, Okano HJ, Masuda M, Ogawa K, Okano H (2006) Proinflammatory cytokines expression in noise-induced damaged cochlea. J Neurosci Res 83(4):575–583

    Article  CAS  PubMed  Google Scholar 

  16. Miyao M, Firestein GS, Keithley EM (2008) Acoustic trauma augments the cochlear immune response to antigen. Laryngoscope 118(10):1801–1808

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Adams JC, Seed B, Lu N, Landry A, Xavier RJ (2009) Selective activation of nuclear factor kappa B in the cochlea by sensory and inflammatory stress. Neuroscience 160(2):530–539

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Masuda M (2013) Cause of idiopathic sudden sensorineural hearing loss: the stress response theory. World J Otorhinolaryngol 3(3):42

    Article  Google Scholar 

  19. Armstrong VW, Schuff-Werner P, Eisenhauer T, Helmhold M, Stix M, Seidel D (1994) Heparin extracorporeal LDL precipitation (HELP): an effective apheresis procedure for lowering Lp(a) levels. Chem Phys Lipids 67–68:315–321

    Article  PubMed  Google Scholar 

  20. Armstrong VW, Schleef J, Thiery J, Muche R, Schuff-Werner P, Eisenhauer T, Seidel D (1989) Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post-treatment return to baseline levels. Eur J Clin Invest 19(3):235–240

    Article  CAS  PubMed  Google Scholar 

  21. Seidel D (1996) H.E.L.P. apheresis therapy in the treatment of severe hypercholesterolemia: 10 years of clinical experience. [Review] [30 refs]. Artif Organs 20(4):303–310

    Article  CAS  PubMed  Google Scholar 

  22. Oreskovic Z, Shejbal D, Bicanic G, Kekic B (2011) Influence of lipoproteins and fibrinogen on pathogenesis of sudden sensorineural hearing loss. J Laryngol Otol 125(3):258–261

    Article  CAS  PubMed  Google Scholar 

  23. Cadoni G, Scorpecci A, Cianfrone F, Giannantonio S, Paludetti G, Lippa S (2010) Serum fatty acids and cardiovascular risk factors in sudden sensorineural hearing loss: a case-control study. Ann Otol Rhinol Laryngol 119(2):82–88

    Article  PubMed  Google Scholar 

  24. Ernst E, Resch KL (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118(12):956–963

    Article  CAS  PubMed  Google Scholar 

  25. Miller JM, Ren TY, Nuttall AL (1995) Studies of inner ear blood flow in animals and human beings. Otolaryngol Neck Surg Off J Am Acad Otolaryngol Neck Surg 112(1):101–113

    Article  CAS  Google Scholar 

  26. Sillman JS, LaRouere MJ, Nuttall AL, Lawrence M, Miller JM (1988) Recent advances in cochlear blood flow measurements. Ann Otol Rhinol Laryngol 97(1):1–8

    Article  CAS  PubMed  Google Scholar 

  27. Shiraishi T, Kubo T, Matsunaga T (1991) Chronological study of recovery of sudden deafness treated with defibrinogenation and steroid therapies

  28. Suckfüll M (2001) Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss. Ther Apher 5(5):377–383

    Article  PubMed  Google Scholar 

  29. Mellwig K-P, Pulawski E, Horstkotte D, Buuren F (2012) Lipid apheresis: oxidative stress, rheology, and vasodilatation. Clini Res Cardiol Suppl 7(S1):45–49

    Article  CAS  Google Scholar 

  30. Hovland A, Lappegård KT, Mollnes TE (2012) LDL apheresis and inflammation–implications for atherosclerosis. Scand J Immunol 76(3):229–236

    Article  CAS  PubMed  Google Scholar 

  31. Stefanutti C, Morozzi C, Petta A (2011) Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia. Cytokine 56(3):842–849

    Article  CAS  PubMed  Google Scholar 

  32. Masuda M, Kanzaki S, Minami S, Kikuchi J, Kanzaki J, Sato H, Ogawa K (2012) Correlations of inflammatory biomarkers with the onset and prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol 33(7):1142–1150

    Article  PubMed  Google Scholar 

  33. Trune D, Nguyen-Huynh A (2012) Vascular pathophysiology in hearing disorders. Semin Hear 33(3):242–250

    Article  PubMed Central  PubMed  Google Scholar 

  34. Zenti MG, Grazia ZM, Stefanutti C, Claudia S (2011) Effects of selective H.E.L.P. LDL-apheresis on plasma inflammatory markers concentration in severe dyslipidemia: implication for anti-inflammatory response. Cytokine 56(3):850–854

    Article  CAS  PubMed  Google Scholar 

  35. Scherer EQ, Yang J, Canis M, Reimann K, Ivanov K, Diehl CD, Backx PH, Wier WG, Strieth S, Wangemann P, Voigtlaender-Bolz J, Lidington D, Bolz SS (2010) TNFα enhances microvascular tone and reduces blood flow in the cochlea via enhanced S1P signaling. Stroke 41(11):2618–2624

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  36. Schettler V, Wieland E (2007) Effects of LDL-apheresis–more than reduction of cholesterol? Dtsch Med Wochenschr 132(11):575–578

    Article  CAS  PubMed  Google Scholar 

  37. Thanaraj S, Hamlin PJ, Ford AC (2010) Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis. Aliment Pharmacol Ther 32(11–12):1297–1306

    Article  CAS  PubMed  Google Scholar 

  38. Kobayashi S, Moriya H, Maesato K, Okamoto K, Ohtake T (2005) LDL-apheresis improves peripheral arterial occlusive disease with an implication for anti-inflammatory effects. J Clin Apher 20(4):239–243

    Article  PubMed  Google Scholar 

  39. Stefanutti C, Vivenzio A, Di Giacomo S, Ferraro PM (2011) Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresis. Cytokine 55(2):245–250

    Article  CAS  PubMed  Google Scholar 

  40. Peter K, Weirich U, Nordt TK, Ruef J, Bode C (1999) Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis. Thromb Haemost 82(Suppl 1):38–43

    PubMed  Google Scholar 

  41. Demirhan E, Eskut NP, Zorlu Y, Cukurova I, Tuna G, Kirkali FG (2013) Blood levels of TNF-α, IL-10, and IL-12 in idiopathic sudden sensorineural hearing loss. Laryngoscope 123(7):1778–1781

    Article  CAS  PubMed  Google Scholar 

  42. Hiramatsu M, Teranishi M, Uchida Y, Nishio N, Suzuki H, Kato K, Otake H, Yoshida T, Tagaya M, Suzuki H, Sone M, Sugiura S, Ando F, Shimokata H, Nakashima T (2012) Polymorphisms in Genes Involved in Inflammatory Pathways in Patients with Sudden Sensorineural Hearing Loss. J Neurogenet 26(3–4):387–396

    Article  CAS  PubMed  Google Scholar 

  43. Hovland A, Hardersen R, Sexton J, Mollnes TE, Lappegård KT (2009) Different inflammatory responses induced by three ldl-lowering apheresis columns. 253:247–253

  44. Gesser B, Leffers H, Jinquan T, Vestergaard C, Kirstein N, Sindet-Pedersen S, Jensen SL, Thestrup-Pedersen K, Larsen CG (1997) Identification of functional domains on human interleukin 10. Proc Natl Acad Sci USA 94(26):14620–14625

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Lio D, Candore G, Crivello A, Scola L, Colonna-Romano G, Cavallone L, Hoffmann E, Caruso M, Licastro F, Caldarera CM, Branzi A, Franceschi C, Caruso C (2004) Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet 41(10):790–794

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  46. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, Ortmann W, Kosoy R, Ferreira RC, Nordmark G, Gunnarsson I, Svenungsson E, Padyukov L, Sturfelt G, Jönsen A, Bengtsson AA, Rantapää-Dahlqvist S, Baechler EC, Brown EE, Alarcón GS, Edberg JC, Ramsey-Goldman R, McGwin G, Reveille JD, Vilá LM, Kimberly RP, Manzi S, Petri MA, Lee A, Gregersen PK, Seldin MF, Rönnblom L, Criswell LA, Syvänen A-C, Behrens TW, Graham RR (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41(11):1228–1233

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. Egli Gallo D, Khojasteh E, Gloor M, Hegemann SCA (2013) Effectiveness of systemic high-dose dexamethasone therapy for idiopathic sudden sensorineural hearing loss. Audiol Neurootol 18(3):161–170

    Article  CAS  PubMed  Google Scholar 

  48. Nosrati-Zarenoe R, Hultcrantz E (2012) Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial. Otol Neurotol 33(4):523–531

    Article  PubMed  Google Scholar 

  49. Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, Ferekidis E (2006) Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 134(6):940–945

    Article  PubMed  Google Scholar 

  50. Ho HG-M, Lin H-C, Shu M-T, Yang C-C, Tsai H-T (2004) Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment

  51. Plontke SK (2010) Intratympanic glucocorticoid therapy of sudden hearing loss. HNO 58(10):1025–1030

    Article  CAS  PubMed  Google Scholar 

  52. Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335(1):2–13

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported financially by the Roland Ernst Foundation for public health care, Dresden and B Braun Avitum AG, Melsungen.

Conflict of interest

Thomas Berger and Andreas Dietz have spoken at congresses sponsored by B Braun Avitium AG and have received honoraria for lecturing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Berger.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Berger, T., Kaiser, T., Scholz, M. et al. Fibrinogen is not a prognostic factor for response to HELP-apheresis in sudden sensorineural hearing loss (SSHL). Eur Arch Otorhinolaryngol 272, 3693–3703 (2015). https://doi.org/10.1007/s00405-014-3449-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-014-3449-9

Keywords

Navigation